10-Q · April 29, 2026
MGP Ingredients reported Q1 2026 results with revenues of $106.4 million, a decline of 13% year-over-year. The net loss for the quarter was $134.8 million, reflecting significant goodwill impairment. The company…
Earnings analysis · 10-Q
MGPI earnings analysis
Filed July 29, 2026 · Our reading of the company's report
The latest report
MGP reported Q2 revenue of $124.357 million, down 15% year over year, as a 42% decline in Distilling Solutions more than offset modest Ingredient Solutions growth and premium-plus spirits growth. Gross margin fell 2.7…
Read full summary
MGP reported Q2 revenue of $124.357 million, down 15% year over year, as a 42% decline in Distilling Solutions more than offset modest Ingredient Solutions growth and premium-plus spirits growth. Gross margin fell 2.7 percentage points to 37.4%, but SG&A and advertising reductions helped preserve a 14.2% operating margin; diluted EPS of $0.55 declined from $0.67 but exceeded the supplied $0.50 consensus estimate. Liquidity remains supported by $574.400 million of combined stated borrowing availability, although year-to-date operating cash flow was a $40.732 million outflow, debt rose to $369.596 million, and a customer bankruptcy required a $2.148 million reserve.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.55
What stood out
-
EPS beat despite year-over-year decline
Q2 diluted EPS was $0.55, down $0.12 or 18% from $0.67 a year earlier, but above the $0.50 consensus estimate supplied. Operating margin improved 0.2 percentage points to 14.2% despite lower sales.
-
Premium-plus spirits continued to grow
Premium-plus Branded Spirits sales increased $1.546 million, or 5%, to $32.645 million; the segment's gross margin improved 0.2 percentage points to 53.0%. Management attributed growth to continued momentum in American whiskey offerings.
-
Ingredient sales returned to modest growth
Ingredient Solutions revenue increased $0.533 million, or 2%, to $35.507 million, led by $1.123 million of biofuel and other sales plus higher specialty wheat starch and protein price/mix.
-
Cost-savings initiatives supported earnings
Cost reductions partly buffered gross-profit pressure: SG&A declined $2.919 million, or 13%, to $20.237 million, while advertising and promotion expense fell $1.230 million, or 18%, to $5.683 million.
-
Substantial stated borrowing capacity
Management states that $338.000 million remained available under its Credit Agreement and $236.400 million under the Note Purchase Agreement at June 30, 2026, and that it met its debt covenants and restrictions.
What to watch
-
Brown-goods demand drove steep sales decline
Consolidated Q2 sales fell $21.137 million, or 15%, to $124.357 million, driven primarily by a $20.780 million, or 42%, decline in Distilling Solutions. Brown-goods revenue fell $20.797 million, or 59%, as elevated industry barrel inventories reduced customer volume demand.
-
Ingredient margin compressed sharply
Gross margin declined 2.7 percentage points to 37.4%. Ingredient Solutions gross profit fell $4.018 million, or 53%, and its margin contracted 11.6 percentage points to 10.1%, primarily from higher waste-starch-stream costs and weaker commodity wheat starch mix.
-
Inventory build turned operating cash flow negative
Year-to-date operating cash flow swung to a $40.732 million outflow from $56.357 million inflow. Inventory growth used $25.631 million of cash, principally from higher barreled-distillate inventory, while inventories totaled $408.416 million at June 30.
-
Debt and interest-rate exposure increased
Total debt increased to $369.596 million at June 30, 2026 from $252.318 million at December 31, 2025, following $116.800 million of net debt proceeds. A 100-basis-point increase in rates would raise annual interest expense by $1.070 million on unhedged variable-rate borrowings.
-
Customer bankruptcy creates collection risk
A significant customer filed for Chapter 11 reorganization on July 26, 2026, prompting a $2.148 million credit-loss allowance and provision. Management is evaluating effects on future sales and collections, and states the ultimate recovery could differ from its estimate.
-
No formal risk-factor update
No new Item 1A risk factors were added in this 10-Q; the filing incorporates the 2025 Form 10-K risk factors. However, the $2.148 million credit-loss provision is a newly quantified operating development disclosed in the quarter.
Management's outlook
The 10-Q does not provide quantitative revenue or EPS guidance. Management expects to incur approximately $20.000 million of 2026 capital expenditures for facility improvement, sustenance, and environmental health and safety projects.
Earlier filings 4
10-K · February 25, 2026
MGP Ingredients describes a three‑pronged strategy across Branded Spirits, Distilling Solutions, and Ingredient Solutions, and says it is "strategically been migrating our sales towards higher price, higher margin…
10-Q · October 29, 2025
MGP Ingredients reported Q3 sales of $130,912 (amounts in the filing are presented in thousands) and diluted EPS of $0.71. Revenue and gross margin declined materially year-over-year (sales down from $161,461 and gross…
10-Q · May 1, 2025
MGP reported Q1 sales of $121,653 (down from $170,563 in Q1 2024) and swung to an operating loss of $(747) from operating income of $28,917 a year ago, producing diluted EPS of $(0.14) versus $0.92. Offsetting the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.